COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease.

ABSTRACT:

Background and aims

COVID-19 vaccine hesitancy varies across the USA. Data on COVID-19 vaccine hesitancy in patients with inflammatory bowel disease (IBD) are lacking. We assessed COVID-19 vaccine hesitancy and its associated variables in patients with IBD.

Methods

We evaluated voluntary patient survey responses during routine clinical visits to our IBD center. Data collected included demographic and clinical characteristics. Descriptive statistics, univariate and multivariate analyses were performed to evaluate significant associations with COVID-19 vaccine hesitancy.

Results

A total of 239 individuals completed the survey. Over a third of respondents (35.6%) expressed hesitancy toward receiving the COVID-19 vaccine due to vaccine safety concerns (49.4%) and efficacy

SUBMITTER: Clarke K 

PROVIDER: S-EPMC8800396 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature